19th International Vaccine Congress and B2B
Event Oct 30 - Oct 31, 2017
Location: Chicago, IL, USA
“19th International Vaccine Congress and B2B Meeting” is going to be held during October 30-31, 2017 at Chicago, USA with the theme “A Global Discussion on technologies, advances and challenges in Vaccines”.
Vaccine Congress 2017 event will include expert presentations, keynote talks, plenary lectures, Entrepreneurs Investment meet, B2B Meetings, Scientific networking etc. where you can have an opportunity to display/talk about your research achievements and contradictions in front of World-class experts, budding scientists & delegates who are gathering from reputed universities and organizations across the globe.
The global vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a growth rate of 11.8% from 2014 to 2019. From global pharmaceutical market sale vaccines occupied very small size of market 2/3% but there is spectacular growth rate 10-15% per year when compare to pharmaceuticals which was 5-7% only. Tripled in value from USD 5B in 2000 to almost USD 24 B in 2013. Influenza vaccine market: estimated at $2.9 billion in 2011 to $3.8 billion by 2018 whereas US market: $1.6 billion in 2011 to $2.2 billion in 2018.
For more information, please visit: http://vaccinecongress.alliedacademies.com/